PATENT CLAIM ANALYSIS

Application Number: 16014971
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["424", "093400"]

Abstract:
Pharmaceutical compositions are disclosed that includes a therapeutically effective amount of a purified viable gram negative bacteria and a pharmaceutically acceptable carrier. The pharmaceutical compositions are formulated for topical administration. Methods of treating atopic dermatitis using these pharmaceutical compositions are also disclosed.

Claim (Index 12):
The method of  claim 1 , wherein the at least one species of  Roseomonas  genus bacterium is topically administered to the subject every other day over a week.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 94.0
- Lexical Diversity: 1.32353
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15939066', '15662691', '14009724', '15976029', '13394113']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7133907748637064
- 35 USC 102 Novelty (BERT): 0.5272031177110692
- Combined Prediction Score: 0.6947720091484427
- Mean Citation Score: 177.209552
- Max Citation Score: 327.67203
- Similarity Product: 232.784181716752

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test